文献速递皮肤肿瘤

HRK差异表达调控获得性黑素细胞痣的增殖

Differential expression of HRK regulates proliferation of acquired melanocytic naevi.
PubMed 文献 · Br J Dermatol · 2026-02-20

本研究对32个痣及邻近皮肤行全转录组测序,发现凋亡相关基因HRK在发育不良痣和带外周球状模式的痣中表达升高,与痣类型显著相关;HRK敲低可降低黑素瘤细胞增殖并增加衰老,提示HRK活性促进逃逸衰老。

要点

  • HRK表达在良性痣、发育不良痣和薄侵袭性黑色素瘤间存在差异。
  • HRK高表达与发育不良痣及外周球状模式痣显著相关。
  • HRK敲低降低黑素瘤细胞增殖并增加衰老细胞。

核心结论

  • HRK在不同亚型痣和黑色素瘤中表达受差异调控,且该差异表达参与调控黑素细胞增殖。

研究设计与样本

  • 使用全转录组测序评估32个经组织病理学和皮肤镜特征表征的痣及匹配的邻近病灶周围皮肤。

主要发现

  • HRK表达升高与发育不良痣显著相关(R2=0.86;P=1.55 x 10-17)。
  • HRK表达升高与带外周球状模式的痣显著相关(R2=0.67;P=1.54 x 10-8)。
  • 免疫组化证实HRK在良性(常规)痣中低表达,在发育不良痣中表达增加,在薄侵袭性T1a黑色素瘤组织中明显增加。
  • 黑素瘤细胞系中siRNA敲低HRK导致BAX(促凋亡)表达高达两倍,sub G0/G1显著增加提示凋亡细胞。
  • HRK表达降低显著减少增殖能力、伤口愈合、集落形成,并增加衰老细胞,表明HRK活性促进逃逸衰老。

临床怎么用

  • HRK表达模式可能有助于区分良性痣、发育不良痣和早期黑色素瘤。
  • HRK活性促进黑素细胞逃逸衰老,或为干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Naevi are considered benign analogues for melanoma, and they share many clinical and molecular features including oncogenic activation, and the transient adoption of senescence-like phenotypes. We previously determined dynamic mechanisms for maintenance of benign naevi (showing conventional features under histopathology) via DNA methylation which was not shared by dysplastic naevi. OBJECTIVES AND METHODS: Using whole-transcriptome sequencing, we evaluated 32 naevi (plus matching adjacent perilesional skin) characterised by histopathology and dermoscopic patterns, to reveal a novel gene-set enriched in actively growing naevi. RESULTS: We focussed on an apoptosis-related gene, HRK (Harakiri/DP5), a Bcl2 family member, which has been found to be downregulated in therapy-induced senescent melanoma cells. Whole transcriptome profiling confirmed that increased HRK expression was significantly correlated (R2=0.86; P=1.55 x 10-17) with dysplastic naevi and in naevi featuring a peripheral rim of globules (R2=0.67; P=1.54 x 10-8). Immunohistochemistry confirmed that HRK was lowly expressed in benign (conventional) naevi compared to dysplastic naevi, with a marked increase in thin invasive T1a melanoma tissues. Next, siRNA knockdown of HRK in melanoma cell lines resulted in up to twofold BAX (pro-apoptotic) expression and significant increases in sub G0/G1, indicative of apoptotic cells. Decreased HRK expression led to significantly reduced proliferative capacity, wound healing, colony formation, and an increase in senescent cells; indicating HRK activity promotes escape from senescence. CONCLUSIONS: In summary, we show HRK expression is distinctly regulated between different subtypes of naevi and melanoma, with supporting evidence this differential expression contributes to regulation of melanocytic proliferation.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Torrano J, Oey HM, Smit DJ, et al. Differential expression of HRK regulates proliferation of acquired melanocytic naevi. Br J Dermatol. 2026. PMID: 41721651. doi:10.1093/bjd/ljag063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。